Europe COPD & Asthma Devices Market (2016-2022) - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Europe COPD & Asthma Devices Market (2016-2022)" report to their offering.

Growing aging population coupled with increasing automotive and industrial exhaust gases have remained the key drivers for the Europe asthma and COPD market. Degrading air quality near the industrial areas has led to the increased incidence of asthma. Increasing disposable income levels in emerging economies as well as developing countries has led to the increased usage of asthma pumps and sprays in these regions. However, the unknown etiology of asthma and COPD in medical industry may hamper the market growth in the next six years. Upcoming treatment methodologies such as once-a-day combination products and monoclonal antibodies have created new opportunities for the market growth. Additionally, pharmaceutical companies have been developing new bio-based medications in combination with bio-technology which promises immense growth opportunities along with sustainable development for asthma & COPD market over the next decade.

The report highlights the adoption of COPD & Asthma Devices in Europe. Based on the product type; the market is segmented into Inhalers and Nebulizers market. Further the Inhaler segment is sub segmented into Dry Powder Inhalers, Metered Dose Inhalers and Soft Mist Inhalers Market. The Nebulizers segment is bifurcated into Pneumatic Nebulizers, Ultrasonic Nebulizers and Mesh Nebulizers Market. The Countries included in the report are Russia, Germany, UK, France, Spain, Italy and Rest of Europe.

Key Topics Covered:

1. Market Scope & Methodology

1.1 Market Definition

1.2 Objectives

1.3 Market Scope

1.4 Segmentation

1.5 Research Methodology

2. Europe COPD and Asthma Devices Market Overview

2.1 Introduction

2.2 Key Influencing Factors

2.3 Europe COPD & Asthma Device Market

3. Europe COPD and Asthma Device Market - By Product Type

4. Europe COPD & Asthma Devices Market - By Country

5. Company Profiles

Companies Mentioned

- Glaxosmithcline PLC

- Novartis International AG

- Merck & Co., Inc.

- AstraZeneca Plc

- 3M Healthcare

- GF Health Products, Inc

- Sunovion Pharmaceuticals Inc.

- Koninklijke Philips N.V.

- Smith Medicals, Inc.

- Baxter International

For more information about this report visit http://www.researchandmarkets.com/research/pwttbw/europe_copd_and

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Respiratory Drugs, Bronchitis Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Respiratory Drugs, Bronchitis Drugs